Literature DB >> 28093001

miR-505-5p and miR-193b-3p: potential biomarkers of imatinib response in patients with chronic myeloid leukemia.

Suganthi S Ramachandran1, Pamchui Muiwo2, Hafiz M Ahmad3, Ravindra Mohan Pandey4, Surender Singh1, Sameer Bakhshi5, Lalit Kumar5, Alok Bhattacharya2, Yogendra Kumar Gupta1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28093001     DOI： 10.1080/10428194.2016.1272681

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  4 in total

Review 1.  MicroRNA-Mediated Regulation of HMGB1 in Human Hepatocellular Carcinoma.

Authors:  Jianing Yan; Shibo Ying; Xiujun Cai
Journal:  Biomed Res Int       Date:  2018-01-31       Impact factor: 3.411

2.  MicroRNA-505-3p inhibits development of glioma by targeting HMGB1 and regulating AKT expression.

Authors:  Zhenlin Cheng; Bin Wang; Cheng Zhang
Journal:  Oncol Lett       Date:  2020-06-09       Impact factor: 2.967

3.  Downregulation of miR‑505‑3p predicts poor bone metastasis‑free survival in prostate cancer.

Authors:  Yubo Tang; Bowen Wu; Shuai Huang; Xinsheng Peng; Xing Li; Xiufang Huang; Wei Zhou; Peigen Xie; Peiheng He
Journal:  Oncol Rep       Date:  2018-10-25       Impact factor: 3.906

4.  LncRNA MVIH knockdown inhibits the malignancy progression through downregulating miR-505 mediated HMGB1 and CCNE2 in acute myeloid leukemia.

Authors:  Shandong Ke; Xiaofen Zhou
Journal:  Transl Cancer Res       Date:  2019-11       Impact factor: 1.241
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.